According to MarkNtel Advisors’ research report titled “Global Blood Screening Market Analysis, 2020”, the Global Blood Screening market is anticipated to grow at a CAGR of around 8.5% during 2020-25F . Full Report - https://www.marknteladvisors.com/research-library/global-blood-screening-market.html

1. Global Blood Screening
Market Analysis, 2020
marknteladvisors.com

2. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 2
Document Outline
Table of Content
Market Segmentation, Scope of Work
05
Research Process & Methodology
Primary Research, Secondary Research, Companies Interviewed, Respondent Profile, Research
Methodology, Forecasting
22
Introduction
About Us, Key Questions Answered In This Study
02
Sample Pages
Global Blood Screening Market Analysis, 2020
30
Commercials 66
Disclaimer 68

3. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 3
Market Segmentation
Global Blood Screening Market Segmentation
• Reagents & Kits
o Nucleic Acid Testing (NAT)
 Enzymes & Polymerases
 Standards & Controls
 Probes & Primers
 Buffers, Nucleotides, and
Solutions
 Labeling & Detection Reagents
o Enzyme-Linked Immunosorbent
Assay (Elisa)
 Immunosorbents
 Controls
 Conjugates
 Substrates
 Sample Diluents & Wash
Solutions
• Instruments
o Rental Purchase
o Outright Purchase
• Software & Services
By Region
• Nucleic Acid Testing
o Transcription-Mediated
Amplification
o Real-Time Polymerase Chain
Reaction
• Enzyme-Linked Immunosorbent
Assay
o Chemiluminescence
Immunoassay
o Fluorescent Immunoassay
o Colorimetric Immunoassays
• Rapid Tests
• Western Blot Assays
• Next-Generation Sequencing (NGS)
By Technology By Company
• Grifols
• Abbott
• Roche
• Bio-Rad
• Biomerieux
• ThermoFisher
• Diasorin
• Perkinelmer
• Trinity Biotech
• BD
• North America
o The US
o Canada
o Mexico
• South America
o Brazil
o Others
• Europe
o Germany
o The UK
o France
o Italy
o Spain
o Others
• Middle East and
Africa
o UAE
o Saudi
Arabia
o South Africa
o Others
• Asia-Pacific
o China
o India
o Japan
o Australia
o Others
By Solution
• Blood Banks
• Hospitals
• Diagnostic Centers & Pathology Labs
• Others (Ambulatory Surgical Centers,
etc.)
By End User

4. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 4
Table of Content (1/15)
Historical Year: 2015
Base Year: 2019
Forecast Year: 2025
Table of Content
1. Introduction
1.1. Product Definition
1.2. Research Process
1.3. Market Segmentation
1.4. Assumptions
2. Executive Summary
3. Global Market Overview
4. Impact of COVID-19 on Global Blood Screening Market
5. Expert Verbatim-Interview Excerpts of industry experts
6. Global Blood Screening Market Outlook, 2015-2025
6.1. Market Size & Analysis
6.1.1. Revenues
6.2. Market Share & Analysis
6.2.1. By Solution
6.2.1.1. Reagents & Kits
6.2.1.1.1. Nucleic Acid Testing (NAT)
6.2.1.1.1.1. Enzymes & Polymerases
6.2.1.1.1.2. Standards & Controls

5. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 5
Table of Content (2/15)
Historical Year: 2015
Base Year: 2019
Forecast Year: 2025
Table of Content
6.2.1.1.1.3. Probes & Primers
6.2.1.1.1.4. Buffers, Nucleotides, and Solutions
6.2.1.1.1.5. Labeling & Detection Reagents
6.2.1.1.2. Enzyme-Linked Immunosorbent Assay (Elisa)
6.2.1.1.2.1. Immunosorbents
6.2.1.1.2.2. Controls
6.2.1.1.2.3. Conjugates
6.2.1.1.2.4. Substrates
6.2.1.1.2.5. Sample Diluents & Wash Solutions
6.2.1.2. Instruments
6.2.1.2.1. Rental Purchase
6.2.1.2.2. Outright Purchase
6.2.1.3. Software & Services
6.2.2. By Technology
6.2.2.1. Nucleic Acid Testing
6.2.2.1.1. Transcription-Mediated Amplification
6.2.2.1.2. Real-Time Polymerase Chain Reaction
6.2.2.2. Enzyme-Linked Immunosorbent Assay

6. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 6
Table of Content (3/15)
Historical Year: 2015
Base Year: 2019
Forecast Year: 2025
Table of Content
6.2.2.2.1. Chemiluminescence Immunoassay
6.2.2.2.2. Fluorescent Immunoassay
6.2.2.2.3. Colorimetric Immunoassays
6.2.2.3. Rapid Tests
6.2.2.4. Western Blot Assays
6.2.2.5. Next-Generation Sequencing (NGS)
6.2.3. By End User
6.2.3.1. Blood Banks
6.2.3.2. Hospitals
6.2.3.3. Diagnostic Centers & Pathology Labs
6.2.3.4. Others (Ambulatory Surgical Centers, etc.)
6.2.4. By Region
6.2.4.1. North America
6.2.4.2. South America
6.2.4.3. Europe
6.2.4.4. Middle East & Africa
6.2.4.5. Asia-Pacific
6.2.5. By Company

7. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 7
Table of Content (4/15)
Historical Year: 2015
Base Year: 2019
Forecast Year: 2025
Table of Content
6.2.5.1. Market Shares, By Revenue
6.2.5.2. Strategic Factorial Indexing
6.2.5.3. Competitor Placement in MarkNtel Quadrant
6.3. Market Attractiveness Index
6.3.1. By Solutions
6.3.2. By Technology
6.3.3. By End User
6.3.4. By Region
7. North America Blood Screening Market Outlook, 2015-2025
7.1. Market Size & Analysis
7.1.1. Revenues
7.2. Market Share & Analysis
7.2.1. By Solutions
7.2.2. By Technology
7.2.3. By End User
7.2.4. By Country
7.2.4.1. The US
7.2.4.2. Canada

8. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 8
Table of Content (5/15)
Historical Year: 2015
Base Year: 2019
Forecast Year: 2025
Table of Content
7.2.4.3. Mexico
7.3. The US Blood Screening Market Outlook, 2015-2025
7.3.1. Market Size & Analysis
7.3.1.1. Revenues
7.3.2. Market Share & Analysis
7.3.2.1. By Solutions
7.3.2.2. By Technology
7.3.2.3. By End User
7.4. Canada Blood Screening Market Outlook, 2015-2025
7.4.1. Market Size & Analysis
7.4.1.1. Revenues
7.4.2. Market Share & Analysis
7.4.2.1. By Solutions
7.4.2.2. By Technology
7.4.2.3. By End User
7.5. Mexico Blood Screening Market Outlook, 2015-2025
7.5.1. Market Size & Analysis
7.5.1.1. Revenues

9. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 9
Table of Content (6/15)
Historical Year: 2015
Base Year: 2019
Forecast Year: 2025
Table of Content
7.5.2. Market Share & Analysis
7.5.2.1. By Solutions
7.5.2.2. By Technology
7.5.2.3. By End User
8. South America Blood Screening Market Outlook, 2015-2025
8.1. Market Size & Analysis
8.1.1. Revenues
8.2. Market Share & Analysis
8.2.1. By Solutions
8.2.2. By Technology
8.2.3. By End User
8.2.4. By Country
8.2.4.1. Brazil
8.2.4.2. Others
8.3. Brazil Blood Screening Market Outlook, 2015-2025
8.3.1. Market Size & Analysis
8.3.1.1. Revenues
8.3.2. Market Share & Analysis

10. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 10
Table of Content (7/15)
Historical Year: 2015
Base Year: 2019
Forecast Year: 2025
Table of Content
8.3.2.1. By Solutions
8.3.2.2. By Technology
8.3.2.3. By End User
9. Europe Blood Screening Market Outlook, 2015-2025
9.1. Market Size & Analysis
9.1.1. Revenues
9.2. Market Share & Analysis
9.2.1. By Solutions
9.2.2. By Technology
9.2.3. By End User
9.2.4. By Country
9.2.4.1. Germany
9.2.4.2. The UK
9.2.4.3. France
9.2.4.4. Italy
9.2.4.5. Spain
9.2.4.6. Others
9.3. Germany Blood Screening Market Outlook, 2015-2025

11. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 11
Table of Content (8/15)
Historical Year: 2015
Base Year: 2019
Forecast Year: 2025
Table of Content
9.3.1. Market Size & Analysis
9.3.1.1. Revenues
9.3.2. Market Share & Analysis
9.3.2.1. By Solutions
9.3.2.2. By Technology
9.3.2.3. By End User
9.4. The UK Blood Screening Market Outlook, 2015-2025
9.4.1. Market Size & Analysis
9.4.1.1. Revenues
9.4.2. Market Share & Analysis
9.4.2.1. By Solutions
9.4.2.2. By Technology
9.4.2.3. By End User
9.5. France Blood Screening Market Outlook, 2015-2025
9.5.1. Market Size & Analysis
9.5.1.1. Revenues
9.5.2. Market Share & Analysis
9.5.2.1. By Solutions

12. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 12
Table of Content (9/15)
Historical Year: 2015
Base Year: 2019
Forecast Year: 2025
Table of Content
9.5.2.2. By Technology
9.5.2.3. By End User
9.6. Italy Blood Screening Market Outlook, 2015-2025
9.6.1. Market Size & Analysis
9.6.1.1. Revenues
9.6.2. Market Share & Analysis
9.6.2.1. By Solutions
9.6.2.2. By Technology
9.6.2.3. By End User
9.7. Spain Blood Screening Market Outlook, 2015-2025
9.7.1. Market Size & Analysis
9.7.1.1. Revenues
9.7.2. Market Share & Analysis
9.7.2.1. By Solutions
9.7.2.2. By Technology
9.7.2.3. By End User
10. Middle East & Africa Blood Screening Market Outlook, 2015-2025
10.1. Market Size & Analysis

13. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 13
Table of Content (10/15)
Historical Year: 2015
Base Year: 2019
Forecast Year: 2025
Table of Content
10.1.1. Revenues
10.2. Market Share & Analysis
10.2.1. By Solutions
10.2.2. By Technology
10.2.3. By End User
10.2.4. By Country
10.2.4.1. UAE
10.2.4.2. Saudi Arabia
10.2.4.3. South Africa
10.2.4.4. Others
10.3. UAE Blood Screening Market Outlook, 2015-2025
10.3.1. Market Size & Analysis
10.3.1.1. Revenues
10.3.2. Market Share & Analysis
10.3.2.1. By Solutions
10.3.2.2. By Technology
10.3.2.3. By End User
10.4. Saudi Arabia Blood Screening Market Outlook, 2015-2025

14. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 14
Table of Content (11/15)
Historical Year: 2015
Base Year: 2019
Forecast Year: 2025
Table of Content
10.4.1. Market Size & Analysis
10.4.1.1. Revenues
10.4.2. Market Share & Analysis
10.4.2.1. By Solutions
10.4.2.2. By Technology
10.4.2.3. By End User
10.5. South Africa Blood Screening Market Outlook, 2015-2025
10.5.1. Market Size & Analysis
10.5.1.1. Revenues
10.5.2. Market Share & Analysis
10.5.2.1. By Solutions
10.5.2.2. By Technology
10.5.2.3. By End User
11. Asia-Pacific Blood Screening Market Outlook, 2015-2025
11.1. Market Size & Analysis
11.1.1. Revenues
11.2. Market Share & Analysis
11.2.1. By Solutions

15. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 15
Table of Content (12/15)
Historical Year: 2015
Base Year: 2019
Forecast Year: 2025
Table of Content
11.2.2. By Technology
11.2.3. By End User
11.2.4. By Country
11.2.4.1. China
11.2.4.2. India
11.2.4.3. Japan
11.2.4.4. Australia
11.2.4.5. Others
11.3. China Blood Screening Market Outlook, 2015-2025
11.3.1. Market Size & Analysis
11.3.1.1. Revenues
11.3.2. Market Share & Analysis
11.3.2.1. By Solutions
11.3.2.2. By Technology
11.3.2.3. By End User
11.4. India Blood Screening Market Outlook, 2015-2025
11.4.1. Market Size & Analysis
11.4.1.1. Revenues

16. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 16
Table of Content (13/15)
Historical Year: 2015
Base Year: 2019
Forecast Year: 2025
Table of Content
11.4.2. Market Share & Analysis
11.4.2.1. By Solutions
11.4.2.2. By Technology
11.4.2.3. By End User
11.5. Japan Blood Screening Market Outlook, 2015-2025
11.5.1. Market Size & Analysis
11.5.1.1. Revenues
11.5.2. Market Share & Analysis
11.5.2.1. By Solutions
11.5.2.2. By Technology
11.5.2.3. By End User
11.6. Australia Blood Screening Market Outlook, 2015-2025
11.6.1. Market Size & Analysis
11.6.1.1. Revenues
11.6.2. Market Share & Analysis
11.6.2.1. By Solutions
11.6.2.2. By Technology
11.6.2.3. By End User

17. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 17
Table of Content (14/15)
Historical Year: 2015
Base Year: 2019
Forecast Year: 2025
Table of Content
12. Global Blood Screening Market Policies, Regulations, Product Standards
13. Global Blood Screening Market Trends & Insights
14. Global Blood Screening Market Dynamics
14.1. Growth Drivers
14.2. Challenges
14.3. Impact Analysis
15. Global Blood Screening Market Hotspot & Opportunities
16. Global Blood Screening Market Key Strategic Imperatives for Success & Growth
17. Competition Outlook
17.1. Competition Matrix
17.1.1. Product Portfolio
17.1.2. Target Markets
17.1.3. Target End Users
17.1.4. Research & Development
17.1.5. Strategic Alliances
17.1.6. Strategic Initiatives
17.2. Company Profiles of top companies (Business Description, Product Segments, Business Segments, Financials,
Strategic Alliances/ Partnerships, Future Plans)
17.2.1. Grifols

18. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 18
Table of Content (15/15)
Historical Year: 2015
Base Year: 2019
Forecast Year: 2025
Table of Content
17.2.2. Abbott
17.2.3. Roche
17.2.4. Bio-Rad
17.2.5. Biomerieux
17.2.6. ThermoFisher
17.2.7. Diasorin
17.2.8. Perkinelmer
17.2.9. Trinity Biotech
17.2.10. BD
18. Disclaimer

19. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 19
Document Outline
Table of Content
Market Segmentation, Scope Of Work
05
Research Process & Methodology
Primary Research, Secondary Research, Companies Interviewed, Respondent Profile, Research
Methodology, Forecasting
22
Introduction
About Us, Key Questions Answered In This Study
02
Sample Pages
Global Blood Screening Market Analysis, 2020
30
Commercials 66
Disclaimer 68

20. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.
Global Blood Screening Market Outlook, 2015-2025F

21. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 21
Global Blood Screening Market Outlook, By Revenues
Figure XX: Global Blood Screening Market Revenues (USD Million), 2015- 2025F
• The global blood screening market is anticipated to surge over the next 5 years owing to the increasing aging population. The blood
transfused in individuals aged more than 60 years in high-income countries is accounting for up to 75% of total transfusions as per the
World Health Organization (WHO). According to the United Nations, worldwide has around 0.7 billion population aged 65 or above in
2019 and is expected to reach about 1 billion by 2030, with the increasing geriatric population, the demand for blood screening solutions
is supposed to augment by 2025.
• The recently spread of COVID-19 across the world is anticipated to restrict the growth of the global blood screening market in 2020 and
consecutive years. This is attributed due to the decreasing number of blood donations and reducing inessential surgical procedures that
lead to reduce demand for blood worldwide.
2015 2016 2017 2018 2019 2020E 2021F 2022F 2023F 2024F 2025F
CAGR
CAGR
Revenue: XX% Revenue: XX%
Source: MarkNtel Advisors

22. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 22
Global Blood Screening Market Outlook, By Revenues
Regions 2019 2050
Asia 395,344 954,681
Europe 140,410 199,895
North America 59,962 96,278
Latin America & the
Caribbean
56,411 144,623
Africa 45,526 143,103
Oceania 5,282 10,271
World Population Aged 65 years or Over (in Thousands)
Source: United Nations

23. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 23
Global Blood Screening Market Revenue Share, By Solution
Figure XX: Global Blood Screening Market Revenue Share (%), By Solution, 2015 - 2025F
• Reagents & Kits: This segment is expected to account for a maximum share during the forecast years. The reagents and kits are used in the
initial stage of blood screening and such solutions are used broadly for rapid and effective detection of transfusion-transmissible diseases
such as hepatitis, cytomegalovirus, etc. across the globe. Moreover, reagents are a cost-effective solution, while instruments comprise high
cost, therefore reagents draw end-users across the globe. These are among the major attributes that anticipated to support the segment to
grow in the coming years.
• The blood transfusion requires in situations such as trauma, pregnancy, and childbirth, etc. worldwide. A growing number of road
accidents and increasing childbirth worldwide have been driving the demand for blood and subsequently, the need for reagents and kits
for blood screening is augmenting from the past few years.
*These are dummy charts and do not represent actual value Source: MarkNtel Advisors
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Reagents & Kits Instruments Software & Services

24. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 24
Global Blood Screening Market Revenue Share, By Reagents & Kits
Figure XX: Global Blood Screening Market Revenue Share (%), By Reagents & Kits, 2019 & 2025F
*These are dummy charts and do not represent actual value Source: MarkNtel Advisors
CAGR: XX%
Key factors: The growing
cases of sickle cell
disease, government
vision to increase medical
tourism
• Nucleic Acid Testing: This is the majorly used solution across the globe from the past few years. Some of the reasons that contribute to
rising the segment growth are as follows:
o Blood transfusion used to provide red blood cells to the patients diagnosed with sickle cell disease, which is diagnosed among
individuals across the globe, particularly in Africa. Hence, the demand for nucleic acid testing is expected to surge for blood
screening globally.
o The government focus towards increasing medical tourism in UAE and Saudi Arabia is supposed to generate the additional demand
for blood in the emirates, thus anticipated that the global nucleic acid testing market is mounting by 2025.
Nucleic Acid Testing
Enzyme-Linked Immunosorbent Assay
2019 2025F
Nucleic Acid Testing
Enzyme-Linked
Immunosorbent
Assay
CAGR: XX%
Key factors: XXX

25. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 25
Global Blood Screening Market Revenue Share, By Enzyme-Linked Immunosorbent
Assay
Figure XX: Global Blood Screening Market Revenue Share (%), By Enzyme-Linked Immunosorbent Assay, 2015 - 2025F
Type 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025F
CAGR
(2020-25)
Immunosorbents XX% XX% XX% XX% XX% XX% XX% XX% XX% XX% XX% XX%
Controls XX% XX% XX% XX% XX% XX% XX% XX% XX% XX% XX% XX%
Conjugates XX% XX% XX% XX% XX% XX% XX% XX% XX% XX% XX% XX%
Substrates XX% XX% XX% XX% XX% XX% XX% XX% XX% XX% XX% XX%
Sample Diluents &
Wash Solutions
XX% XX% XX% XX% XX% XX% XX% XX% XX% XX% XX% XX%
Source: MarkNtel Advisors

26. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 26
Global Blood Screening Market Size, By Technology
Figure XX: Global Blood Screening Market Size (USD Million), By Technology, 2019 & 2025F
• Nucleic Acid Testing segment is anticipated to dominate the global blood screening market during the forecast years 2020-25. This is
attributed due to high sensitivity feature than other alternatives and specificity for viral nucleic acids such as DNA and RNA. Moreover, this
technology has been improved the accuracy of identifying the viral agents in a small time period, therefore, the demand for nucleic acid
testing technology is boosting from the past few years.
• While the Enzyme-Linked Immunosorbent Assay (ELISA) market is projected to rise owing to availability at low cost, continuous
improvement to surge the specificity and the rising probability of developing infectious diseases among individuals across the globe,
particularly in Asia-Pacific region.
*These are dummy charts and do not represent actual value Source: MarkNtel Advisors
2019 2025F
Nucleic Acid Testing
Enzyme-Linked Immunosorbent
Assay
Rapid Tests
Western Blot Assays
Next-Generation Sequencing
Nucleic Acid Testing
Enzyme-Linked Immunosorbent
Assay
Rapid Tests
Western Blot Assays
Next-Generation Sequencing

27. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 27
Global Blood Screening Market Attractiveness Index, By Region
0
0.5
1
1.5
2
2.5
3
0% 1% 2% 3% 4% 5% 6%
Market Size (2019- USD mn Vs CAGR 2020-25 (Percentage)
North America
Middle East & Africa
South America
Asia-Pacific
Europe
Market
Size,
2019
(USD
Mn)
CAGR (2020-2025)
*These are dummy charts and do not represent actual value Source: MarkNtel Advisors

28. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved.
North America Blood Screening Market Outlook, 2015-2025F

29. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 29
North America Blood Screening Market Outlook, By Revenues
Figure XX: North America Blood Screening Market Revenues (USD Million), 2015- 2025F
• North America is projected to dominate the global blood screening market during the forecast years 2020-25. Some factors that contribute
to the growth of North America market are as follows:
o The presence of major blood screening players coupled with increasing research and development for introducing new products is
driving the North America market from the past few years. For instance: Roche launched Zika blood screening test in January 2020,
this product help the end-users to screen the donated blood in the region.
o The surging number of patients diagnosed with cardiovascular disease is anticipated to increase the number of cardiac surgeries in
North America. Blood transfusion majorly used in cardiac surgical procedures, this would generate the demand for more blood in
the healthcare settings and would augment the demand for blood screening solutions over the next 5 years.
2015 2016 2017 2018 2019 2020E 2021F 2022F 2023F 2024F 2025F
CAGR
CAGR
Revenue: XX% Revenue: XX%
Source: MarkNtel Advisors

30. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 30
North America Blood Screening Market Revenue Share, By Solution
Figure XX: North America Blood Screening Market Revenue Share (%), By Solution, 2015 - 2025F
*These are dummy charts and do not represent actual value Source: MarkNtel Advisors
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Reagents & Kits Instruments Software & Services
• Reagents & Kits: The availability of a broad range of reagents & kits in the region, surging risk of new pathogens, and mandate screening of
some diseases such as hepatitis B, hepatitis C, HIV, etc. in North America are driving the reagents and kits segment from the past few years.
Moreover, the growing awareness about early diagnosis coupled with increasing adoption of the advanced method of blood screening in
healthcare settings is expected to drive the segment growth over the next 5 years.
• The reimbursement policy for the treatment of several diseases is expected to add more patients' footfall in the region, which expected to
generate the requirement for blood transfusion, thus the demand for blood would escalate in the coming years. Therefore, anticipated that
the sale of blood screening reagents and kits would boost during the forecast years 2020-25.

31. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 31
North America Blood Screening Market Revenue Share & Market Size, By Reagents &
Kits
Figure XX: North America Blood Screening Market Revenue Share (%) & Market Size (USD Million), By Reagents & Kits, 2019 & 2025F
*These are dummy charts and do not represent actual value Source: MarkNtel Advisors
Nucleic Acid Testing
Enzyme-Linked Immunosorbent Assay
2019 2025F
Nucleic Acid Testing
Enzyme-Linked
Immunosorbent
Assay
CAGR: XX%
Key factors:
XXX
CAGR: XX%
Key factors:
XXX
Solutions 2019 2025F CAGR (2020-25)
Nucleic Acid Testing XX XX XX%
Enzyme-Linked Immunosorbent
Assay
XX XX XX%

32. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 32
North America Blood Screening Market Revenue Share, By Enzyme-Linked
Immunosorbent Assay
Figure XX: North America Blood Screening Market Revenue Share (%), By Enzyme-Linked Immunosorbent Assay, 2015 - 2025F
Type 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025F
CAGR
(2020-25)
Immunosorbents XX% XX% XX% XX% XX% XX% XX% XX% XX% XX% XX% XX%
Controls XX% XX% XX% XX% XX% XX% XX% XX% XX% XX% XX% XX%
Conjugates XX% XX% XX% XX% XX% XX% XX% XX% XX% XX% XX% XX%
Substrates XX% XX% XX% XX% XX% XX% XX% XX% XX% XX% XX% XX%
Sample Diluents &
Wash Solutions
XX% XX% XX% XX% XX% XX% XX% XX% XX% XX% XX% XX%
Source: MarkNtel Advisors

33. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 33
Document Outline
Table of Content
Market Segmentation, Scope of Work
05
Research Process & Methodology
Primary Research, Secondary Research, Companies Interviewed, Respondent Profile, Research
Methodology, Forecasting
22
Introduction
About Us, Key Questions Answered In This Study
02
Sample Pages
Global Blood Screening Market Analysis, 2020
30
Commercial 66
Disclaimer 68

34. Copyright 2020. Reproduction is forbidden unless authorized. All rights reserved. 34
+1 (613) 707-5086
sales@marknteladvisors.com